Recent Posts
- Naveris’ Head and Neck Cancer Recurrence Detection Study Selected for Presentation at ASTRO 2022 Plenary Session
- Natick Company Develops Test to Detect Head and Neck Cancer that Could Lead to Earlier Diagnosis
- New Saliva Test Detects Head and Neck Cancer
- Naveris, Inc. Raises $19 Million in Financing to Advance and Commercialize Blood Tests for Early Detection of HPV and Other Viral-Related Cancers
- HPV Head and Neck Cancer Recurrence Test Data Adds Validation as Naveris Ramps Clinical Launch
Recent Comments